Myriad Genetics, Inc. (MYGN) was reiterated a ‘Neutral’ by Mizuho on Tuesday. The broker also raised its price target on the stock to $38 from $32. Firm notes it’s increasing the stock’s 12-month base case estimate following Myriad’s Analyst Day. Mizuho believes the company’s new long-term outlook, which is above consensus, looks achievable, but notes that several moving parts need to work.
MYGN shares recently gained $1.42 to $40.69. The stock is up 7.50% year-over-year and 15.30% year-to-date. In the past 52 weeks, shares of Salt Lake City, Utah-based personalized medicine company have traded between a low of $30.30 and a high of $41.18.
Myriad Genetics, Inc. closed Monday at $39.27. The name has a current market cap of $2.79 billion.
Analysts at JP Morgan (JPM) are out with a report this morning upgrading shares of SAP SE (SAP) with a ‘Overweight’ from ‘Neutral’ rating.
SAP SE ADR shares are currently priced at 23.06x this year’s forecasted earnings, which makes them quite expensive compared to the industry’s 2.01x earnings multiple. Ticker has a forward P/E of 15.88 and t-12 price-to-sales ratio of 3.64. EPS for the same period is $2.90.
In the past 52 weeks, shares of Walldorf, Germany-based company have traded between a low of $62.82 and a high of $77.50 and are now at $66.84.
Shares are down 13.69% year-over-year and 4.04% year-to-date.
Analysts at Citigroup (C) upgraded their rating on the shares of Teradyne Inc. (TER). In a research note published on Tuesday, the firm lifted the name with a ‘Buy’ from ‘Neutral’ rating and set a 12-month base case estimate of $24 from $20.50 per share.
On valuation measures, Teradyne Inc. shares are currently priced at 35.95x this year’s forecasted earnings, compared to the industry’s 11.61x earnings multiple. Ticker has a PEG and forward P/E ratio of 1.32 and 12.97, respectively. Price/Sales for the same period is 2.28 while EPS is $0.53. Currently there are 8 analysts that rate TER a ‘Buy’, 5 rate it a ‘Hold’. No analyst rates it a ‘Sell’. TER has a median Wall Street price target of $22.50 with a high target of $26.00.
Nordstrom Inc. (JWN) was raised to ‘Buy’ from ‘Hold’ with $84 price target at Stifel on Tuesday.
JWN is up $1.49 at $74.67 on good volume. Midway through trading Tuesday, 1.08 million shares of Nordstrom Inc. have exchanged hands as compared to its average daily volume of 1.61 million shares. The stock has ranged in a price between $73.88 to $74.99 after having opened the day at $74.05 as compared to the previous trading day’s close of $73.18.
In the past 52 weeks, shares of Seattle, Washington-based fashion specialty retailer have traded between a low of $66.08 and a high of $83.16.
Shares are up 7.96% year-over-year ; down 6.46% year-to-date.
Weight Watchers International, Inc. (WTW) was upgraded to ‘Buy’ from ‘Hold’ by Craig Hallum analysts on Tuesday.
WTW is currently printing a higher than average trading volume with the issue trading 3.25 million shares, compared to the average volume of 1.23 million. The stock began trading this morning at $6.12 to currently trade 13.41% higher from the prior days close of $5.74. On an intraday basis it has gotten as low as $6.03 and as high as $6.78.
Weight Watchers International Inc. shares are priced at 5.72x this year’s forecasted earnings, compared to the industry’s 15.33x earnings multiple. The company’s current year and next year EPS growth estimates stand at (67%) and (26.9%) compared to the industry growth rates of 6.50% and 23.70%, respectively. WTW has a t-12 price-to-sales ratio of 0.25. EPS for the same period registers at $1.14.
WTW shares have declined 5.75% in the last 4 weeks while advancing 17.38% in the past three months. Over the past 5 trading sessions the stock has lost 6.67%. The New York-based weight management services provider, which is currently valued at $372.44 million, has a median Wall Street price target of $5.00 with a high target of $6.00.
Weight Watchers International Inc. is down 75.14% year-over-year, compared with a 2.30% loss in the S&P 500.